Michael Lundborg, DPM
Foot & Ankle Surgery · Tumwater, WANPI 1487037867
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,000 of the $15,934 with a category attached, or 62.8%. Treace Medical Concepts, Inc. accounts for 79.1% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $7,795 and has fallen 90.9% since, to $713 in 2025.
Across 94 payments — averaging $169.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$13K
- Paragon 28, Inc.$1K
- Arthrex$751
- Smith+Nephew$388
- Fusion Orthopedics USA, LLC$365
- Nevro Corp.$194
- plus $378 from 8 others
What the payments were for
- Consulting fees$10,00063%
- Travel & lodging$1,4369%
- Food & beverage$3,78424%
- Education$7144%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 48 | $12,601 |
| Paragon 28, Inc. | 5 | $1,257 |
| Arthrex | 2 | $751 |
| Smith+Nephew | 10 | $388 |
| Fusion Orthopedics USA, LLC | 14 | $365 |
| Nevro Corp. | 4 | $194 |
| CPM Medical Consultants, LLC | 2 | $155 |
| Organogenesis Inc. | 2 | $55 |
| Henry Schein, Inc. | 1 | $44 |
| Johnson & Johnson | 2 | $27 |
| Triad Life Sciences Inc. | 1 | $26 |
| Bioventus LLC | 1 | $26 |
| Biowound Solutions, Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$11,457
- Stravix$149
How this compares
$15,934 in reported general payments places this provider in the 85th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 74 | $793 |
| Diclofenac Sodium | 12 | $740 |
| Ciclopirox | 12 | $511 |
| Gabapentin | 15 | $205 |
| Terbinafine Hcl | 22 | $182 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 28 | $150 |
| Ondansetron OdtOndansetron | 11 | $116 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Tumwater
- Jeffrey ChristensenEverett$828K
- David DalstromSeattle$491K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
- Garrett PereskoMorton$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.